Europe’s first commercial psychedelic testing facility is set to open in London to make the UK a world leader in psychedelic research and innovation. From the report: British startup Clerkenwell Health aims to start trials at its London center in August, initially focusing on the use of psilocybin to help people cope with anxiety associated with a diagnosis of incurable disease, and support them at the end of life. care. This news is when scientists and politicians gather in London this Wednesday for the agenda of the Symposium on Psyche, a one-day program to discuss the latest research and the future of the psychedelic industry in Europe.

Source by [author_name]

Previous articleJudge Lebagan Madiba has been appointed the new President of the Special Tribunal
Next articleStandard Bank employees were fired for violations in activating the account